1 "한국중앙암등록 사업 연례 보고서 (2002. 1.- 2002. 12.)" 한국중앙암등록본부 2003
2 Lee KW, "Vitamin C and cancer chemoprevention: Reappraisal" 78 : 1074-1078, 2003
3 VandeCreek L, "Use of alternative therapies among breast cancer outpatients compared with the general population" 5 : 71-76, 1999
4 Drisko JA, "The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer" 22 : 118-123, 2003
5 "The prevalence of complementary/ alternative medicine in cancer: A systematic review" 83 : 777-782, 1998
6 "Stromal cel oxidation: A mechanism by which tumors obtain vitamin C" 57 : 4555-4558, 1999
7 Prasad KN, "Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies" 20 : 450-463, 2004
8 "Revaluation of ascorbate in cancer treatment: Emerging evidence, open minds and serendipity" 19 : 423-425, 2000
9 Whitney CW, "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study" 17 : 1339-1348, 1999
10 "Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tisues" 102 : 13604-13609, 2005
1 "한국중앙암등록 사업 연례 보고서 (2002. 1.- 2002. 12.)" 한국중앙암등록본부 2003
2 Lee KW, "Vitamin C and cancer chemoprevention: Reappraisal" 78 : 1074-1078, 2003
3 VandeCreek L, "Use of alternative therapies among breast cancer outpatients compared with the general population" 5 : 71-76, 1999
4 Drisko JA, "The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer" 22 : 118-123, 2003
5 "The prevalence of complementary/ alternative medicine in cancer: A systematic review" 83 : 777-782, 1998
6 "Stromal cel oxidation: A mechanism by which tumors obtain vitamin C" 57 : 4555-4558, 1999
7 Prasad KN, "Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies" 20 : 450-463, 2004
8 "Revaluation of ascorbate in cancer treatment: Emerging evidence, open minds and serendipity" 19 : 423-425, 2000
9 Whitney CW, "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study" 17 : 1339-1348, 1999
10 "Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tisues" 102 : 13604-13609, 2005
11 "Intravenous vitamin C as a chemotherapy agent: A report on clinical cases" 23 : 115-118, 2004
12 Riordan NH, "Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent" 44 : 207-213, 1995
13 "High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy" 137-41,
14 "High doses of antioxidants in ovarian cancer multiple antioxidant vita-mins: Essential ingredients in improving the efficacy of standard cancer therapy" 18 : 13-25, 1999
15 "Fre radicals and antioxidants in chemotherapy induced toxicity" 23 : 209-240, 1997
16 "Cytotoxicity of ascorbate, lipoic acid, andother antioxidants in hollow fibre in vitro tumours" 84 : 1544-1550, 2001
17 "Cytotoxic efect of ascorbate and its derivatives on cultured malignant and nonmalignant cel lines" 475-80,
18 "Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology" 18 : 2505-2014, 2000
19 Riordan NH, "Clinical and experi-mental experiences with intravenous vitamin C" 5 : 201-213, 2000
20 "Cancer statistics 2002" 52 : 23-47, 2002
21 "A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients" 24 : 269-276, 2005